 |
 |
 |
 |
 |
 |
 |
 |
E. William Radany, Ph.D., President and Chief Executive Officer
has over 25 years experience in the biotechnology industry. Prior to joining CODA, he was President and CEO of High Throughput Genomics, Inc., a provider of novel array-based gene expression assay technology for the life science industry. Dr. Radany was also previously President of Biacore, founder and CEO of NeoGenex and has held executive positions at Xencor, Caliper Technologies and Stratagene.
Stephen Picataggio , Ph.D., Chief Scientific Officer
has over 30 years experience in metabolic engineering of industrial microorganisms and developing fermentation processes for the production of fuels and chemicals. Prior to joining CODA, Dr. Picataggio was Vice President of Metabolic Engineering at Synthetic Genomics, Inc., and held various leadership positions at DuPont, the National Renewable Energy Laboratory and Henkel/Cognis Corp. Steve has a B.S., magna cum laude, in Bacteriology and Public Health and a Ph.D. in Microbiology, and was a Postdoctoral Research Associate at the Massachusetts Institute of Technology. He is the recipient of several awards and an inventor on more than 45 issued and pending patents.
Steve Jackson, Chief Financial Officer
is a CPA with over 20 years of progressive accounting and finance experience. Prior to joining CODA , he was a principal in a small consulting firm practicing process improvement and SOX Compliance, Director of Internal Audit at REMEC Inc., Vice President at SAIC, a Fortune 500 defense contractor, and Senior Consultant at Price Waterhouse.
Alan Carter, Senior Vice President of Business Development and Marketing
has a broad range of pharmaceutical and research program strategic development through commercial management experiences with Biotrove, Gene Logic, Celera Genomics and Applied Biosystems.
Nancy Oleski, Ph.D., J.D., Senior Vice President of Intellectual Property and General Counsel
has been practicing law in the biotechnology industry for over seventeen years. Prior to joining CODA Genomics, she served as in-house consel at Amgen, Inc., Nuvelo, Inc., and Codexis, Inc.